JiscMail Logo
Email discussion lists for the UK Education and Research communities

Help for LIS-E-RESOURCES Archives


LIS-E-RESOURCES Archives

LIS-E-RESOURCES Archives


LIS-E-RESOURCES@JISCMAIL.AC.UK


View:

Message:

[

First

|

Previous

|

Next

|

Last

]

By Topic:

[

First

|

Previous

|

Next

|

Last

]

By Author:

[

First

|

Previous

|

Next

|

Last

]

Font:

Proportional Font

LISTSERV Archives

LISTSERV Archives

LIS-E-RESOURCES Home

LIS-E-RESOURCES Home

LIS-E-RESOURCES  2006

LIS-E-RESOURCES 2006

Options

Subscribe or Unsubscribe

Subscribe or Unsubscribe

Log In

Log In

Get Password

Get Password

Subject:

Accucoms sign first US sales representation

From:

amy williams <[log in to unmask]>

Reply-To:

An informal open list set up by the UK Serials Group <[log in to unmask]>

Date:

Tue, 21 Nov 2006 16:05:55 +0000

Content-Type:

text/plain

Parts/Attachments:

Parts/Attachments

text/plain (77 lines)

Apologies for cross-posting. The attached may be of interest to some of the
readers of this list.

For immediate release
21st November 2006
Ref: 0806

ACCUCOMS announces first signing for US sales representation

ACCUCOMS BV, a leading provider of sales and marketing services to scholarly
and society publishers, today announced its first signing for US sales
representation, just a few weeks after the launch of the service at the
October Frankfurt Book Fair.

Future Science Group has appointed ACCUCOMS to provide locally-based sales
representation in North America. The service includes researching leads,
visiting potential customers, giving demonstrations, arranging trial access
and negotiating site license access for individual institutions, large
corporations, multi-nationals and consortia.

"We are excited about the potential that our partnership with ACCUCOMS
offers," said Stephen Galt, Sales Manager at Future Science Group. "The US
is the largest single market on the planet.  As an STM publisher it seemed
very limiting not to have a resource based in North America. ACCUCOMS have
been able to offer us an affordable way to enhance our presence in the US,
but also to gain direct feedback from this important market, so we can
better understand our customers and their needs."

Since launching their US and European-based sales representation service,
ACCUCOMS have been pleased with the level of interest that it has attracted.
"There is clearly a need for publishers to be able to tap into the sales
support we can offer," commented Egon Menardi.  "Wešve been inundated with
enquires since we launched the service and are delighted to be moving
forward so quickly with Future Science Group."

Future Science Group was looking for a particular kind of approach from a
sales representation service. "The difference that ACCUCOMS offer is that
they understand that real sales success is not built on one-off
transactions, but on developing lasting relationships ­ which is as much
about listening and responding to our customers as well as selling to them,"
said Stephen Galt. "This is what keeps us ahead as a business, and why we
chose ACCUCOMS to provide this service."

­ Ends ­

About ACCUCOMS

ACCUCOMS BV is an independent company providing specialist sales and
marketing services for scholarly and society publishers worldwide. Based in
The Netherlands, with a satellite office in the US, ACCUCOMS provides
cost-effective and efficient inbound and outbound telemarketing, sales
representation and support, market research and customer service.

 
About Future Science Group
Future Science Group Ltd, based in London, has developed an innovative
publishing portfolio to reflect post-genomic medicine. The sequencing of the
human genome was a colossal milestone in the evolution of healthcare, with
repercussions for all those involved in the healthcare chain.  Through its
imprints, Future Medicine and Future Drugs, Future Science Group Ltd
provides healthcare practitioners and research professionals with a unique
source of objective, cutting-edge information on exciting trends emerging in
the light of these advances. Our flagship title Pharmacogenomics has evolved
to become a leading source of commentary and analysis from international
opinion leaders. Momentum towards an individualized approach to medicine is
increasing as the value of linking diagnostic and therapeutic approaches
becomes ever clearer.  For more information please access:
www.future-drugs.com and www.futuremedicine.com.

 
For further information, contact:
Egon Menardi
T: +31 252 430636
[log in to unmask]

 

Top of Message | Previous Page | Permalink

JiscMail Tools


RSS Feeds and Sharing


Advanced Options


Archives

May 2024
April 2024
March 2024
February 2024
January 2024
December 2023
November 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
April 2023
March 2023
February 2023
January 2023
December 2022
November 2022
October 2022
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
2006
2005
2004
2003
2002
2001
2000
1999


JiscMail is a Jisc service.

View our service policies at https://www.jiscmail.ac.uk/policyandsecurity/ and Jisc's privacy policy at https://www.jisc.ac.uk/website/privacy-notice

For help and support help@jisc.ac.uk

Secured by F-Secure Anti-Virus CataList Email List Search Powered by the LISTSERV Email List Manager